Immunomodulation Effect of Metabolites from Lactobacillus Rhamnosus GG on Interleukins Release in Vitro

Edyta Balejko^1, , Anna Bogacka¹, Jerzy Balejko² and Elżbieta Kucharska¹

¹Department of Human Nutrition, West Pomeranian University of Technology in Szczecin, Poland

²Department of Food Process Engineering, West Pomeranian University of Technology in Szczecin, Poland

Cite this paper:
Edyta Balejko, Anna Bogacka, Jerzy Balejko and Elżbieta Kucharska. Immunomodulation Effect of Metabolites from Lactobacillus Rhamnosus GG on Interleukins Release in Vitro. Journal of Food and Nutrition Research. 2015; 3(5):297-302. doi: 10.12691/jfnr-3-5-2

Abstract

The aim of the study was to determine in vitro whether the metabolites of Lactobacillus rhamnosus GG stimulate the release of selected cytokines from lymphocytes. Cell cultures from whole human blood were established. The concentration of TGF-β1, IFN-γ and IL-4 was determined in cultures liquid by ELISA. Lactobacillus GG rods were immobilized in alginate microcapsules. To determine the tightness of the capsules their surfaces were observed by electron microscopy. During 14 days the migration of the bacteria to outside of the capsules was not observed. In liquid from cell cultures of lymphocytes the increase of TGF-β1 and IL-4 and the decrease in IFN-γ concentration were observed, influenced by Lactobacillus GG metabolites enclosed in lyophilized alginate microcapsules, as compared to control group. The possible stimulants were exopolysaccharide and Lactobacillus GG metabolites, i.e. lactic acid, nitrogen oxide and hydrogen peroxide.

Keywords:
microencapsulation immunomodulation TGF-β1 IFN-γ IL-4 probiotics

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	WHO/FAO Guidelines for the evaluation of probiotics in food. Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. World Health Organization, London Ontario Canada. 2002 Page 8. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
[2]	Madaliński, K, Szajewska, H, “Probiotics: Mechanism of effect, immunomodulation and potential use in alimentary gastrointestinal diseases,” Zakażenia, 5, 42-48, 2004.
[3]	Vaarala, O, “Immunological effects of probiotics with special reference to lactobacilli,” Clin Exp Allergy, 33, 1634-1640, 2003.
[4]	Limdi, J.K., O’Neill, C., McLaughlin J., “Do probiotics have a therapeutic role in gastroenterology?,” World J Gastroenterol, 12(34), 5447-5457, Sept.2006.
[5]	Ewaschuk, J.B., Dieleman, L.A., “Probiotics and prebiotics in chronic inflammatory bowel diseases,” World J Gastroenterol, 12(37), 5941-5950, Oct.2006.
[6]	Kirjavainen, P.V., Apostolou, E., Salminen, S.J., Isolauri, E., “New aspect of probiotics – a novel approach in the management of food allergy,” Alergia Astma Immunol, 6(1), 1-6, 2001.
[7]	Klein, A., Friedrich, U., Vogelsang, H., Jahreis, G., “Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults,” Eur J Clin Nutr, 62, 584-593, 2008.
[8]	Chin-Feng, L., Kuo-Chuan, T., Shen-Shih, Ch., Bao-Hong, L., Wei-Hsuan, H., Tzu-Ming, P., “Immunomodulatory and antioxidant potential of Lactobacillus exopolysaccharides,” Journal of the Science of Food and Agriculture, 91, 12, 2284-2291, 2011.
[9]	Wickens, K., Stanley, T.V., Mitchell, E.A., Barthow, C., Fitzharris, P., Purdie, G., Siebers, R., Black, P.N., Crane, J., “Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?,” Clin Exp Allergy, 43(9), 1048-57, Sep.2013.
[10]	Stahl, B., M'Rabet, L., Vos Arjan, P., Garssen, J., Boehm, G., “Immunomodulating,” Nr pat. 06111971.5 PL/EP 1733730, 25.10.2004.
[11]	Stanisz, A., Accessible course in statistics based on STATISTICA software exemplified with medical data (in Polish), StatSoft INc, Kraków, Tom 1, 1998.
[12]	Dobosz, M., Computer aided statistical analysis of research data (in Polish), Akademicka Oficyna Wydawnicza EXIT, Warszawa, 2001.
[13]	Cukrowska, B., Czarnowska, E., “The influence of probiotics on the immune system,” Zakażenia, 1, 59-64, 2007.
[14]	Sudo, N., Sawamura, S., Tanaka, K., Aiba, Y., Kubo, C., Koga, Y., “The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction,” J Immunol, 159, 1739-1745, Aug.1997.
[15]	Cross, M.L., Ganner, A., Teilab, D., Fray, L.M., “Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria,” FEMS Immunol Med Microbiol, 42(2), 173-180, 2004.
[16]	Ghadimi, D., Folster–Holst, R., de Vrese, M., Winkler, P., Heller, K.J., Schrezenmeir, J., “Effects of probiotic bacteria and their genomic DNA on T(H)1/T(H)2- cytokine production by peripheral blood mononuclear cells. (PBMCs) of healthy and allergic subjects,” Immunobiology, 213(8), 677-692, Apr.2008.
[17]	Helwig, U., Lammers, K.M., Rizello, F., Brigidi, P., Rohleder, V., Caramelli, E., Gionchetti, P., Schrezenmeir, J., Foelsch, U.R., Schreiber, S., Campieri, M., “Lactobacilli, bifidobacteria and E. coli nissle induce pro-and anti-inflammatory cytokines in peripheral blood mononuclear cells,” World J Gastroenterol, 12(37), 5978-5986, Oct.2006.
[18]	Kukkonen, K., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T., Kuitunen, M., “Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placedo- controlled trial,” J Allergy Clin Immunol, 119(1), 192-198, Oct.2006.
[19]	Savilahti, E., Kuitunen, M., Vaarala, O., “Pre and probiotics in the prevention and treatment of food allergy,” Curr Opin Allergy Clin Immunol, 8, 243-248, 2008.
[20]	Roitt, I., Brostoff, J., Male, D., Immunology, Wydawnictwo Lekarskie PZWL, Wydawnictwo Medyczne Słotwińskie Verlag Brema, Warszawa, 2000.
[21]	Gołąb, J., Jakóbisiak, M., Lasek, W., Stokłosa, T., Immunology, Wydawnictwo Naukowe PWN, Warszawa, 2010.
[22]	Pessi, T., Sutas, Y., Hurme, M., Isoluari, E., “Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG,” Clin Exp Allergy, 30(12), 1804-1808, Dec.2000.
[23]	Balejko, E., Kucharska, E., Bartkowiak, A., “Influence of Lactobacillus rhamnosus GG metabolites on immunological processes in vitro,” Centr Eur J Immunol, 34(3), 147-153, 2009.
[24]	Balejko, E., Kucharska, E., Balejko, J., “Effect of Lactobacillus rhamnosus GG encapsulation on interleukin 10 release in vitro,” Centr Eur J Immunol, 38(1), 37-41, 2013.
[25]	Kopp, M. V., Goldstein, M., Dietschek, A., Sofke, A., Heinzmann, A., Urbanek, R., „Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-γ release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates,” Clinical & Experimental Allergy, 38(4), 602-610, 2008.
[26]	Kekkonen, R.A., Kajasto, E., Miettinen, M., Veckman, V., Korpela, R., Julkunen, I., “Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production,” World J Gastroenterol, 14(8), 1192-1203, Feb.2008.
[27]	Sutas, Y., Hurme, M., Isolauri, E., “Down-regulation of anti-CD3 antibody- induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG- derived enzymes,” Scand J Immunol, 43(6), 687-689, Jun.1996.
[28]	Dong, H., Rowland, I., Yaqoob, P., “Comparative effects of six probiotic strains on immune function in vitro,” British Journal of Nutrition, 108(03), 459-470, Aug.2012.
[29]	Majamaa, H., Isolauri, E., “Probiotics: a novel approach in the management of food allergy,” J Allergy Clin Immunol, 99(2), 179-185, Feb.1997.
[30]	Elmadfa, I., Klein, P., Meyer, A.L., “Prebiotics and probiotics usefulness against pathologies Immune-stimulating effects of lactic acid bacteria in vivo and in vitro,” Proceeding of the Nutrition Society, 69, 416-420, 2010.
[31]	Kekkonen, R.A., Lummela. N., Karjalainen, H., Latvala, S., Tynkkynen, S., Jarvenpaa, S., Kautiainen, H., Julkunen, I., Vapaatalo, H., Korpela, R., “Probiotic intervention has strain- specific anti-inflamatory effects in healthy adults,” World J Gastroenterol, 14(13), 2029-2036, Apr.2008.
[32]	Cukrowska, B., Ceregra, A., Rosiak, I., “Probiotics in prophylactis and treatment of atopic dermatitis,” Zakażenia, 6(2), 55-60, 2006.
[33]	Martirosian, G., “The probiotics for certain anaerobic bacteria digestive tract,” Progress in Medicine Infections, 11(7-8), 741-743, 1993.
[34]	Salminen, S., Wright, A., Lactic acid bacteria. Dekker. New York. 1993.